Andrea Marra

Ο λογιστικοσ

[Uriel Suárez @UsuarezMD]

Hairy-Cell Leukemia | New England Journal of Medicine https://t.co/os7uz8W4BL

[roberto bellelli @robertobellell1]

We have an exciting PhD project available within the @CRUKCOLcentre at @QMBCI to investigate novel mechanisms of sensitization to PARP inhibitors. Enthusiasts in genome stability and cancer therapeutics get in touch and apply ! please RT
https://t.co/642QfYlhty

[Itai Yanai @ItaiYanai]

How did we lose our tail? A simple question.. but it wasn't really asked before! We discovered a plausible scenario for the genetic mechanism that led to tail loss. Amazing that such a big change may have been caused by such a small genetic event. https://t.co/0ZR8aH23PJ @BoXia7

[AmericanJournalofHematology @AjHematology]

Targeting mitochondrial apoptosis in BRAF-V600E+ hairy B cell neoplasm with clinical resistance to BRAF inhibition

https://t.co/ANJWhpjSCU

[Blood Cancer Discovery @BCD_AACR]

Attending #ASH23?
Read the Clonal Hematopoiesis Collection.
https://t.co/fTOEO4wWHS

[Andrea Marra @andreamarra87]

https://t.co/sUqeailoFD @Haematologica

[roberto bellelli @robertobellell1]

We have a PhD project available within the @CRUKCOL network at @QMBCI to explore novel mechanisms of genome and epigenome stability at the replication fork.
Get in touch if you are interested and apply ! please RT

[roberto bellelli @robertobellell1]

We have a 3 years post-doc position in my lab at @QMBCI to investigate novel mechanisms of genetic and epigenetic stability. Cool project and fantastic place to work, in the heart of London ! Please RT and get in touch if you are interested !

https://t.co/FwYzkw0RF9

[roberto bellelli @robertobellell1]

Deadline extended to 19th May to apply for a post-doc position in my lab at @QMBCI to investigate mechanisms of genetic stability at the replication fork. Get in touch if you are interested! https://t.co/4hSpFGGEj9

[Blood Cancer Discovery @BCD_AACR]

Molecular evolution of classic #Hodgkinlymphoma revealed through whole genome sequencing of Hodgkin and #ReedSternberg cells, by @FrancescoMaura4, @LisaRoth_MD et al.
https://t.co/DVXmCOWIjP
@WeillCornell #lymsm #cancergenomics

[Marco @MarcoGargaro]

Honoured to have been awarded an ERC Starting Grant #ERCStG for the project REACT-DC about innovative therapeutic solutions to fight cancer disease. My thanks to @UniperugiaNews and especially to @ERC_Research for the precious opportunity to contribute to the oncology research.

[SIICA Immunologia @SiicaI]

Latest scientific publication from our #SIICA members #Gargaro and #Fallarino @UniperugiaNews on @ImmunityCP showing that IDO1 pathway induces regulatory cDC2 via AhR-mediated metabolic communication.
https://t.co/ueSo1XZ2CY

#siica_official #immunity #immunology #scienceforall

[Immunity @ImmunityCP]

cDC1 to cDC2: “Everything I do, Ido1 it for you” https://t.co/02PSbD7pfR

[teresa zelante’s lab @TeresaZelante]

@MarcoGargaro @Francescafallarino wonderful piece of science in DC biology… congrat!!!

[Andrea Marra @andreamarra87]

Congrats @MarcoGargaro

[Andrea Marra @andreamarra87]

Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication: Immunity https://t.co/KpoAzOtpXR

[Blood Cancer Discovery @BCD_AACR]

Check out the collection on clonal hematopoiesis in Blood Cancer Discovery:
https://t.co/fMtEtZyfQy

[AIL - Ass. Italiana Leucemie linfomi e mieloma @AIL_ets]

Studiare la regolazione immunologica dei megacariociti nell’ambito della #LeucemiaMieloideAcuta NPM1 mutata, il sottotipo più comune di LMA.
Questo lo scopo del progetto premiato dalla #Sies e e finanziato da AIL grazie al contributo dei grandi donatori dell'Associazione.

[Blood Cancer Discovery @BCD_AACR]

#ICYMI: Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin #Lymphoma by Enrico Tiacci, Alessandra Venanzi, and colleagues.
https://t.co/n9Vof9ZF5z

[Giulia Pianigiani @GPianigiani87]

Fantastic data presented by our colleague Dr. @andreamarra87 on T Cell Immunotherapy in High Risk AML #SIES2021